Application 201355
- Type
- ANDA
- Sponsor
- NOSTRUM LABS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NITROFURANTOIN | NITROFURANTOIN | SUSPENSION;ORAL | 25MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70408-239 | NITROFURANTOIN | NITROFURANTOIN | Nostrum Laboratories, Inc. | ANDA | Current |
| 70408-239 | NITROFURANTOIN | NITROFURANTOIN | Nostrum Laboratories, Inc. | ANDA | Current |
| 70408-239 | NITROFURANTOIN | NITROFURANTOIN | Nostrum Laboratories, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 69649 | ORIG | 2021-12-20 |